2012 Program
| Tuesday, September 4, 2012 | |||
| 6:00-7:30 | Opening Reception Dr. Jeffrey Morse, Managing Director, National Nanomanufacturing Network Vincent Caprio, Executive Director, NanoBusiness Commercialization Association |
||
| Why You Should Pay Attention When Science Fiction Gets it Wrong Special Guest Star: Harry Steinman, Author of Little Deadly Things |
|||
| Wednesday, September 5, 2012 | |||
| 7:30 | Registration Opens Continental Breakfast served in the Showcase/Poster Session Area |
||
| 8:25 | Opening Remarks Dr. Jeffrey Morse, Managing Director, National Nanomanufacturing Network Vincent Caprio, Executive Director, NanoBusiness Commercialization Association |
||
| 8:30-9:10 | Keynote: Robert C. Pohanka, Ph.D., Director, National Nanotechnology Coordination Office (NNCO) | ||
| 9:10-9:45 | Keynote: Dmitry Akhanov, President & CEO, RUSNANO | ||
| 9:45-10:30 | Keynote: Dr. Mihail C. Roco, Senior Advisor for Nanotechnology, National Science Foundation | ||
| 10:30-10:45 | Break | ||
| EHS | Nanotechnology Commercialization | ||
| 10:45-12:45 | State of the Union Nanotechnology Environmental Health Safety (EHS) 2012 Session Chair: J. A. Isaacs, Acting Chair and Professor, Mechanical & Industrial Engineering, Associate Director, Center for High-rate Nanomanufacturing Sally Tinkle, Ph.D., Deputy Director & EHS Coordinator, NNCO Kenneth F. Martinez, MSEE, CIH; Field Studies Team Leader, Nanotechnology Research Center, Education and Information Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention |
Session Chair: Vincent Caprio, Executive Director, NanoBusiness Commercialization Association | |
| 10:45-11:15 | Paul S. Clayson, President & CEO, HzO, Inc. | ||
| 11:15-12:15 | Competing in the New Patent Era - Major Shifts Begin 9/16/12 Moderator: J. Steven Rutt, Partner and Chair, Nanotechnology Industry Team, Foley & Lardner LLP Mick Sawka, Director of Business Development, Office of Technology Development, Harvard University James C. De Vellis, Senior Counsel, Electronics Practice Group, Foley & Lardner LLP David Sossen, Technology Licensing Officer, MIT Dr. Henning Richter, Director of Materials Synthesis Research, Nano-C |
||
| 12:15-12:45 | Converting One to a Million, a Scale-up Process for Nanotechnology Commercialization Bob Predmore, PE, Senior Vice-President, Nano-PM |
||
| 12:45-1:15 | Lunch | ||
| 1:15-2:00 | Luncheon Keynote: FBI, Special Agent - Nanotechnology Protection | ||
| Nanomanufacturing | Nanotechnology Investing & Capital Formation | ||
| 2:00-4:00 | Nanomanufacturing Innovation Session Chair: Dr. Jeffrey Morse, Managing Director, National Nanomanufacturing Network Ahmed Busnaina, Ph.D., Director, NSF Center for High-Rate Nanomanufacturing (CHN), Northeastern University James Watkins, Ph.D., Director, NSF Center for Hierarchical Manufacturing (CHM), UMass Amherst Vladimir Bulovic, Ph.D., Director, Microsystems Technology Laboratories, MIT Heat Assisted Scalable Plasmonic Nanomanufacturing |
2:00-3:00 | Nano to Dough: Challenges and Approaches to Nano Funding and Commercialization LG Almeda, Intellectual Property Attorney, Brinks Hofer Gilson & Lione Stephen R. Waite, Managing Partner, SoundView Technology Group David E. Burnett, President and Co-Founder, nanoScience Engineering Corporation |
| Nanomedicine & Nanodiagnostics | |||
| 3:00-4:30 | Nano Tx, Rx: Clinical, Business and Regulatory Perspectives Session Chair: Mostafa Analoui, Ph.D., Head of Healthcare & Life Sciences, Livingston Securities George Hinkal, Ph.D., Office of Cancer Nanotechnology Research, National Cancer Institute Dr. Hong Guo, Vice President of Research, pSivida Inc. Dr. Subhas Malghan, FDA, Deputy Director in the Office of Science and Eng Lab, Center for Devices and Radiological Health (CDRH) Anil Diwan, Ph.D., Chairman and President, NanoViricides, Inc. Guillaume Pfefer, Ph.D., MBA, President & CEO, Kala Pharmaceuticals, Inc. |
||
| 4:00-4:15 | Break | ||
| Nanomanufacturing | |||
| 4:15-5:30 | Nanotechnology Development Via User Facilities Lloyd Whitman, Deputy Director, Center for Nanoscale Science and Technology, NIST Eric Martin, Ph.D., Technical Director, Center for Nanoscale Systems, Harvard University Joey Mead, Ph.D., Co-Director, Nanomanufacturing Center of Excellence, UMass Lowell |
Nanotechnology Investing & Capital Formation | |
| 4:30-5:30 | Successfully Overcoming the Valley of Death Fern O'Brian, Partner, Thompson Hine LLP Scott Livingston, Chairman & CEO, Livingston Securities Thomas M. Haas, Counsel, Intellectual Property, Thompson Hine LLP |
||
| 5:30 | Keynote: Scott Livingston, Chairman & CEO, Livingston Securities | ||
| 5:30-7:30 | Reception Showcase Area & Poster Session |
||
| Thursday, September 6, 2012 | |||
| 7:30 | Registration Opens Continental Breakfast served in the Showcase/Poster Session Area |
||
| 8:25 | Opening Remarks Vincent Caprio, Executive Director, NanoBusiness Commercialization Association Dr. Jeffrey Morse, Managing Director, National Nanomanufacturing Network |
||
| 8:30-9:00 | Keynote: Doug Jamison, Chairman of the Board, CEO & Managing Director, Harris & Harris Group | ||
| 9:00-9:30 | Keynote: Jim Phillips, Chairman/CEO, NanoMech | ||
| 9:30-10:00 | Keynote: David J. Arthur, CEO, SouthWest NanoTechnologies Inc. | ||
| 10:00-10:30 | Keynote: Jess A. Jankowski, President & CEO, Nanophase | ||
| 10:30-10:45 | Break | ||
| Nanotechnology Commercialization | Nanomaterials | ||
| 10:45-12:45 | Successful Nanotechnology Transition from RSL Initiatives Session Chair: Griffith Kundahl, Executive Director, Center of Innovation for Nanobiotechnology Robert D. "Skip" Rung, President & Executive Director, ONAMI John Brewer, CEO, Amorphyx; and Entrepreneur-in-Residence, ONAMI Miles C. Wright, CEO, Xanofi Zagit Gaymalov, Ph.D., CEO, NeuroNano Pharma Steven Warwick, CEO, NanoForge Dr. Christie M. Sayes, Program Manager - Nanotoxicology & Nanopharmacology Center for Aerosols & Nanomaterials Engineering, RTI International Kyle Chenet, Vice President, Corporate Development, Liquidia Technologies, Inc Tom Tiano, Senior Program Manager, NanoTechLabs Inc. |
10:45-11:15 | How to Combine Nanotech with Business Success Anthony Vicari, Research Associate, Lux Research |
| Nanotechnology and the Law | |||
| 11:15-12:15 |
Minimizing Legal Exposure: Are you Ready for a Lawsuit by a Patent Troll or Tort Attorney? Jack B. Hicks, Partner & Patent Attorney, Womble Carlyle Sandridge & Rice, LLP; Adjunct Professor, Elon University School of Law John Parker Sweeney, Attorney at Law, Womble Carlyle Sandridge & Rice, LLP Vincent Caprio, Executive Director, NanoBusiness Commercialization Association |
||
| Nanomaterials | |||
| 12:15-12:45 | Best Practices of Commercializing Nanotechnology in EU Dr. Eeva Viinikka, Programme Director, National Nanotechnology Cluster Programme, Culminatum Innovation Ltd Oy |
||
| 12:45-1:15 | Lunch | ||
| 1:15-2:00 | Luncheon Keynote: Sally Gutierrez, Director ORD National Risk Management Research Lab, EPA | ||
| 2:00-2:30 | Don Ewert, IH, VP - Field Services; nanoTox, Inc.Past-Chair; AIHA Nanotechnology Working Group | ||
| 2:30-3:00 | Keynote: Joe Piché, CEO, Eikos | ||
| Nanotechnology Commercialization | |||
| 3:00-4:00 | Top 20 Nanotech Innovators - Major Corporations & Top 20 Emerging Nanotech Innovators Vincent Caprio, Executive Director, NanoBusiness Commercialization Association Griffith Kundahl, Executive Director, Center of Innovation for Nanobiotechnology Graeme Ossey, Research & Marketing Manager, Center of Innovation for Nanobiotechnology |
||
| 4:00-4:15 | Closing Remarks Vincent Caprio, Executive Director, NanoBusiness Commercialization Association Dr. Jeffrey Morse, Managing Director, National Nanomanufacturing Network |
||
| 4:15-6:00 | Reception Showcase Area & Poster Session |
||
